The 20 analysts offering 12-month price forecasts for Amgen Inc have a median target of 250.00, with a high estimate of 277.00 and a low estimate of 173.00. The median estimate represents a +10.54% increase from the last price of 226.17.
The current consensus among 26 polled investment analysts is to Hold stock in Amgen Inc. This rating has held steady since December, when it was downgraded from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share $3.41
Reporting Date Jan 31
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.